|
Butterfield,
D. A., A. Castegna, C. M. Lauderback, and J. Drake. 2002. Evidence that
amyloid
beta-peptide-induced lipid peroxidation and its sequelae in
Alzheimer’s disease brain contribute to neuronal death. Neurobiol. Aging 23
(5): 655-664.
Butterfield,
D. A., J. Drake, C. Pocernich, and A. Castegna. 2001. Evidence of oxidative
damage
in Alzheimer’s disease brain: central role for amyloid b-peptide.
Trends in Mol. Med. 7 (12): 548-554.
Butterfield, D. A. and C. M.
Lauderback. 2002. Lipid peroxidation and protein oxidation in
Alzheimer's
disease brain: potential causes and consequences involving amyloid
beta-peptide-associated free radical oxidative stress. Free Radic. Biol. Med. 32
(11): 1050-1060.
to and alters
the structure and DNA interactions of histones: Implications for DNA
oxidation in Alzheimer’s disease. Manuscript
in preparation.
Esterbauer, H., R. J. Schaur, and
H. Zollner. 1991. Chemistry and biochemistry of 4-
hydroxynonenal,
malonaldehyde and related aldehydes.
Free Radic. Biol. Med. 11
(1):81-128.
Halliwell, B. 2001. Role of free radicals in the
neurodegenerative diseases. Therapeutic implications
for antioxidant treatment. Drugs and
Aging. 18 (9): 685-716.
Hensley, K., N. Hall, R.
Subramaniam, P. Cole, M. Harris, M. Aksenov, M. Aksenova, P.
Gabbita, J.
F. Wu, J. M. Carney, M. Lovell, W. R. Markesbery, and D. A. Butterfield.
1995. Brain regional correspondence between Alzheimer’s disease
histopathology and biomarkers of protein oxidation. J. Neurochem. 65:
2146-2156.
Katzman,
R. and T. Saitoh. 1991. Advances in Alzheimer’s disease. FASEB J. 4: 278-286.
Koppal,
T., J. Drake, and D. A. Butterfield. 1999. In vivo modulation of rodent
glutathione and
its role in peroxynitrite-induced neocortical synaptosomal
membrane protein damage. Biochim.
Biophys. Acta. 1453 (3):
407-411.
Kurt, M.
A., D. C. Dabies, M. Kidd, K. Duff, S. C. Rolph, K. H. Jennings, and D. R.
Howlett.
2001. Neurodegerative Changes Associated with b-Amyloid
Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein
and Mutant Presenilin-1 Transgenes. Exp.
Neurol. 171: 59-71.
La Fontaine, M.A., J. W. Geddes,
A. Banks, and D. A. Butterfield. 2000. Effect of exogenous
and endogenous
antioxidants on 3-nitropionic acid-induced in vivo oxidative stress and
striatal lesions: insights into Huntington's disease. J. Neurochem. 75 (4):
1709-1715.
and D. A.
Butterfield. 2001. The glial glutamate transporter, GLT-1, is oxidatively
modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of
Abeta1-42. J. Neurochem. 78 (2): 413-416.
Li, W., S. Nagaraja, G. P.
Delcluve, M. J. Hendzel, and J. R. Davie. 1993. Effects of histone
acetylation,
ubiquitination and variants on nucleosome stability. Biochem. J. 296
(3):737-744.
Lovell, M. A., W. D. Ehmann, M.
P. Mattson, and W. R. Markesbery. 1997. Elevated 4-
hydroxynonenal
in ventricular fluid in Alzheimer's disease. Neurobiol. Aging 18
(5):457-461.
Markesbery, W. R. 1997. Oxidative
stress hypothesis in Alzheimer’s disease. Free
Radic. Biol.
Med. 23 (1): 134-147.
peroxidation, is
increased in the brain in Alzheimer's disease. Neurobiol. Aging 19 (1):33-36.
increased in
Alzheimer's disease. Ann. Neurochem. 36 (5):747-751.
Pocernich, C. B., A. L. Cardin,
C. L. Racine, C. M. Lauderbeck, and D. A. Butterfield. 2001.
Glutathione
elevation and its protective role in acrolein-induced protein damage in
synaptosomal membranes: relevance to brain lipid peroxidation in
neurodegenerative disease. Neurochem. Int. 39 (2): 141-149.
Pocernich, C. B., M. La Fontaine,
and D. A. Butterfield. 2000. In-vivo glutathione elevation
protects against
hydroxyl free radical-induced protein oxidation in rat brain. Neurochem.
Int. 36 (3): 185-191.
Selkoe,
D. J. 2001. Presenilin, Notch, and the genesis of treatment of Alzheimer’s
disease. PNAS
98 (20): 11039-11041.
Subramaniam, R., F. Roediger, B.
Jordan, M. P. Mattson, J. N. Keller, G. Waeg, and D. A.
Butterfield.
1997. The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the
conformation of cortical synaptosomal membrane proteins. J. Neurochem. 69
(3):1161-1169.
of DNA binding
on the degradation of oxidized histones by the 20S proteasome. Arch. Biochem. Biophys. 362 (2): 211-216.
Varadarajan,
S., S. Yatin, M. Askenova, and D. A. Butterfield. 2000. Review: Alzheimer’s
Amyloid b-Peptide-Associated Free radical Oxidative Stress and
Neurotoxicity. J. Struc. Biol. 130: 184-208.
Yan, S. D., X. Chen, J. Fu, M.
Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J.
Morser, A.
Migheli, P. Nawroth, D. Stern, and .A . M. Schmidt. 1996. RAGE and amyloid-b
peptide neurotoxicity in Alzheimer’s disease. Nature 382 (6593):
685-691.
Amyloid
beta-Peptide (1-42)-Induced Neuronal Protein Oxidation and Reactive Oxygen
Species Production. J. Alzheimers Dis.
2 (2): 123-131.
|